Charles Cartwright

Charles Cartwright currently serves as the Senior Vice President of Clinical and Regulatory Affairs at Detect, a position held since April 2024. Prior to this role, Charles was the Vice President of Strategic Development at Serosep Ltd., where responsibilities included expanding the company into the US clinical market and providing strategic intelligence to senior leadership. Previously, Charles held several senior roles at SpeeDx Pty Ltd, focusing on clinical operations and scientific affairs, where notable achievements included managing clinical study plans and negotiating crucial agreements. Charles's extensive experience includes a decade at LabCorp, where leadership in microbiology, immunology, and infectious disease resulted in significant revenue growth and operational efficiency. Charles holds a PhD in Microbiology from the University of Bath and a BSc (Hons.) in Biological Sciences from the University of Wolverhampton.